Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

Christina N Kontoghiorghe, George J Kontoghiorghes Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol, Cyprus Abstract: The prevalence rate of thalassemia, which is endemic in Southeast Asia, the Middle East, and the Mediterranean, exceeds 100,000 live birth...

Full description

Bibliographic Details
Main Authors: Kontoghiorghe CN, Kontoghiorghes GJ
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:Drug Design, Development and Therapy
Subjects:
thalassemia intermedia
non transfusion dependent thalassemia
chelation therapy
deferiprone
deferoxamine
deferasirox
Online Access:https://www.dovepress.com/efficacy-and-safety-of-iron-chelation-therapy-with-deferoxamine-deferi-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/efficacy-and-safety-of-iron-chelation-therapy-with-deferoxamine-deferi-peer-reviewed-article-DDDT

Similar Items